Figshare
open access
Antiplatelet therapy in peripheral arterial disease. Consensus statement
Objectives: Antiplatelet agents are commonly prescribed to reduce the risk of myocardial infarction, stroke and graft occlusion in patients with peripheral arterial disease (PAD). The objective was to summarise current evidence and provide recommendations on the use of antiplatelet agents in PAD. Me
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Peripheral Artery Disease and Sepsis Outcomes#804001
- Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD)#1229422
- Intra-arterial Versus Systemic Thrombolysis for Acute Ischemic Stroke#1350081
- Delivery of Yamani-15/5 Chemical Solution for PAD#1173029
- Antiplatelet Therapy Continuation in Spine Surgery - Its Effect on Postoperative Morbidity and Mortality#230329
Record · ID 1373413
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive